Answers are grounded in this paper and cite their sources.
Osteosarcoma is a highly aggressive bone tumor characterized by profound chemoresistance and immune evasion, resulting in poor clinical prognoses. The rational design of metallodrugs to overcome these obstacles is a formidable challenge, as traditional discovery methods are inefficient for predicting the organelle-specific targeting required for specific mechanisms of action. Here, we introduce a machine learning-driven platform to rationally design and identify endoplasmic reticulum (ER)-targeting Ga(III) complexes capable of activating nonapoptotic immunogenic cell death. This strategy identified Ga20, a complex that triggers a dual mechanism of paraptosis and immunogenic cell death (ICD), directly addressing osteosarcoma’s apoptosis resistance. Formulated as a polymeric nanoparticle (Ga NP) for targeted in vivo delivery, this nanomedicine demonstrated profound tumor growth inhibition across aggressive and clinically relevant orthotopic, metastatic, bilateral, and patient-derived xenograft models. Critically, Ga NP treatment generated a durable in situ vaccine effect, conferring long-term immune memory and preventing tumor recurrence and metastasis. This work establishes a strategy for the computational design of organelle-targeted metallodrugs and presents a powerful chemoimmunotherapy that directly addresses the core clinical challenges of osteosarcoma.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: